Enval has created a way to recycle previously un-recyclable materials in a process based on microwave-induced pyrolysis.

The business successfully raised £985,950 through SyndicateRoom in 2015 with the intention of ramping up its commercial scale plant to full capacity.

The story

Enval’s story began at the University of Cambridge when a bacon roll was microwaved for so long that it turned into a glowing mass of carbon. This sparked further experiments, resulting in the eventual formation of Enval: a solution that extracts 100% of usable aluminium (as well as fuel and other valuable materials) from previously un-recyclable laminate packaging, 160,000 tonnes of which enters the UK marketplace each year and inevitably ends up in landfill.

This process is based on microwave-induced pyrolysis, which heats waste laminates (such as toothpaste tubes, pet food pouches, drinks pouches etc) in the absence of oxygen to extract valuable materials without emitting greenhouse gases or toxic emissions.

Enval is part of a Department for Environment, Food and Rural Affairs (Defra) research programme to introduce plastic aluminium laminates into existing household recycling schemes. In 2010 Enval constructed its pilot plant. The first commercial demonstration plant was built following investment and support from major multinational FMCG brands, including Nestlé, Kraft Foods and Mondel ēz International.

Where are they now?

In 2017 Enval was named winner of the Green Award at the SME National Business Awards; you can watch the video of the presentation here. The award celebrates businesses that are ‘reducing or removing the harmful impact that products and/or services have on the environment.’

In June 2018 Enval was shortlisted for the UK Business Angels Association Awards in the category of Best Investment in Disruptive Tech.

You can find more updates on Enval’s press page.

See current opportunities

The Diabetic Boot Company

EIS
Medtech
Developing a unique wound healing device, focussed on saving diabetics from lower limb amputations. The global market for this product exceeds $1 billion.

Active

Trading status

£21,784

Average investment

£1,764,494

Total raised

Bactest - Round 2

EIS
Pharmaceuticals & Biotechnology
Bactest develops and sells products based on its propriety technology platform that turns microbial activity into data.

No longer trading

Trading status

£12,070

Average investment

£301,760

Total raised

Fertility Focus - Round 2

EIS
Medtech
The only product on the market that detects ovulation with 99% accuracy, Fertility Focus raised funds on SyndicateRoom. Read about the raise here.

Active

Trading status

£10,917

Average investment

£360,250

Total raised

CommonTime Limited

EIS
Software & Computer Services
A new way to make, mobilise and manage business mobile applications. 2011 Rolls-Royce Innovative Business of the Year with £2m in revenue in 2014.

Active

Trading status

£26,611

Average investment

£745,099

Total raised

Calon Cardio

EIS
Medtech
New hope to thousands of Advanced Heart Failure patients at a cost health systems can afford.

Active

Trading status

£29,512

Average investment

£1,210,000

Total raised

Radio Physics Solutions

EIS
Technology, Hardware & Equipment
Radio Physics Solutions aim to make the world a more secure place. Read about the company's second fund raise here.

Active

Trading status

£8,143

Average investment

£586,288

Total raised